Now, the startup has raised £1.4 million to scale its business to commercialise into the US market, with the potential to help over 70 million insomnia sufferers. A sleeptech startup from the UK, SleepCogni has developed a ground-breaking treatment for insomnia. , SleepCogni has developed a ground-breaking treatment for insomnia that allows users to control their wind down process using a unique handheld medical device and platform. SleepCogni is a great example of hardware and software working together to have a truly life changing impact on patients.”Andrew Morfey, a former Finance Director at AXA Health-On-Line who subsequently led AXA Health’s development of their £10m well-being platform.